Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Sarilumab
Kevzara
Not routinely available
SMC (SMC2810)
28/05/2025
Indication
Treatment of polymyalgia rheumatica (PMR) in adult patients who have had an inadequate response to corticosteroids or who experience a relapse during corticosteroid taper.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
Solution for injection in pre-filled pen & pre-filled syringe
Comments
Link to Advice
Advice Published
12/05/2025
SMC Submission Type
Non submission
SMC Status
Not recommended